AU1925501A - Complexes of alkylphosphonic acids - Google Patents

Complexes of alkylphosphonic acids

Info

Publication number
AU1925501A
AU1925501A AU19255/01A AU1925501A AU1925501A AU 1925501 A AU1925501 A AU 1925501A AU 19255/01 A AU19255/01 A AU 19255/01A AU 1925501 A AU1925501 A AU 1925501A AU 1925501 A AU1925501 A AU 1925501A
Authority
AU
Australia
Prior art keywords
complexes
alkylphosphonic acids
alkylphosphonic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19255/01A
Inventor
Marcus Helfrich
Catherine Page
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Oregon
Original Assignee
University of Oregon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Oregon filed Critical University of Oregon
Publication of AU1925501A publication Critical patent/AU1925501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1227—Micelles, e.g. phospholipidic or polymeric micelles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Materials Engineering (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU19255/01A 1999-11-24 2000-11-22 Complexes of alkylphosphonic acids Abandoned AU1925501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16742799P 1999-11-24 1999-11-24
US60167427 1999-11-24
PCT/US2000/032057 WO2001037883A1 (en) 1999-11-24 2000-11-22 Complexes of alkylphosphonic acids

Publications (1)

Publication Number Publication Date
AU1925501A true AU1925501A (en) 2001-06-04

Family

ID=22607340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19255/01A Abandoned AU1925501A (en) 1999-11-24 2000-11-22 Complexes of alkylphosphonic acids

Country Status (2)

Country Link
AU (1) AU1925501A (en)
WO (1) WO2001037883A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381426B2 (en) 2002-01-24 2008-06-03 Southwest Research Institute Targeted delivery of bioactive factors to the systemic skeleton
DE10222481A1 (en) * 2002-05-22 2003-12-04 Eucro Europe Contract Res Gmbh Contrast agent for use in imaging
JP2007502833A (en) * 2003-08-21 2007-02-15 サウスウエスト・リサーチ・インスティチュート Nanoparticles targeted to the skeleton
US7311901B2 (en) * 2003-10-10 2007-12-25 Samyang Corporation Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
AU705549B2 (en) * 1995-06-07 1999-05-27 Promega Biosciences, Inc. Phosphonic acid-based cationic lipids

Also Published As

Publication number Publication date
WO2001037883A1 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
AU6972398A (en) Phosphonic acid derivatives
AU6482398A (en) Sulfonylaminocarboxylic acids
AU2006699A (en) Phosphinic alkanoic acid derivatives
AU2557500A (en) Methods of making compounds
AU7164198A (en) Method of preparing salicyloylamino acids
AU6045900A (en) Interaction-activated proteins
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU5047399A (en) Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition
AU1893901A (en) Connector
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU2001273761A1 (en) Preparation of (r)-2-alkyl-3-phenylpropionic acids
AU2445601A (en) Mammalian protein phosphatases
AU1268400A (en) Isothiazolecarboxylic acid derivatives
AU4932899A (en) Processes for the preparation of metallocene complexes
AU5382200A (en) Muc1 ligands
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU5536599A (en) Process for the preparation of neotame
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU5504999A (en) Production of proteins
AU3488700A (en) Luminescent metal-ligand complexes
AU3248000A (en) Manufacture of polyketones
AUPP193498A0 (en) Cemetery walls
AU9650398A (en) Piperazine-cyclodextrin complexes
AU1925501A (en) Complexes of alkylphosphonic acids
AU7075498A (en) Process for the preparation of trifluoroethoxyarenecarboxylic acids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase